Figure 3 from Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin by Joanna Domagala (21643925)

CORT triggered a slow-onset increase in GluN2A/GluN2B ratio. by Yiu Chung Tse (340737)

“…<p>(<b>A</b>) Plots of NMDAR-EPSC amplitude from control and CORT-treated slices against time show decreased EPSC amplitude after sequential application of Ro (1 µM; for 30 min) and a mixture of Ro and a subunit non-selective NMDAR antagonist APV (50 µM; for 10 min). …”

The kinases TTBK1/2 phosphorylate TDP-43 in <i>C. elegans</i> and <i>in vitro</i>. by Nicole F. Liachko (669572)

“…<p>(A) Developmentally synchronized day 1 adult <i>dkf-2(−/−)</i>;TDP-43, <i>cdc-7(−/−)</i>;TDP-43, and H05L14.1(−/−);TDP-43 kinase mutants have decreased phosphorylated TDP-43 relative to TDP-43 transgenic animals alone. …”

Depletion of SAMHD1 causes cellular R-loop accumulation. by Kiwon Park (6492266)

CFD-DEM Coupling Simulation and Cross-Scale Correlation Analysis of a Liquid-Containing Gas–Solid Spouted Fluidized Bed Reactor by Delong Feng (9075738)

“…When μ < 50 mPa·s, higher viscosity increases large agglomerates and decreases small agglomerates. …”

Decision curve analysis of PIERS-ML model on day 0 (a), day 4 (b), day 8 (c), and day 13 (d). by Guiyou Yang (10259597)

Decision curve analysis on day 0 (a), day 4 (b), day 8 (c), and day 13 (d) (fullPIERS model). by Guiyou Yang (10259597)

Summary of the RuvB2 co-IP. by Tim Vellmer (12837414)

Visualization of a classified 3D volume. by Amrita Das Gupta (17364749)

“…Here, we introduce NuCLear (<u>Nu</u>cleus-instructed tissue <u>c</u>omposition using deep <u>lear</u>ning), an approach combining in vivo two-photon imaging of histone 2B-eGFP-labeled cell nuclei with subsequent deep learning-based identification of cell types from structural features of the respective cell nuclei. …”

The inactivation of the acetyl-CoA acyltransferase 1 enzyme by the novel putative miRNA Oeu124369 leads to a decrease in Acetyl-CoA production and additionally, the deactivation of... by Mohammad Hossein Pakdel (19837942)

Kaplan-meier survival analysis of 360 EOC patients. by Mirielle C. Ma (18990490)

Longer-term consequences of Tax expression on the host cell. by Saumya Ramanayake (7879091)

Depletion of SAMHD1 induces R-loop-mediated genome instability and cellular DNA damage response. by Kiwon Park (6492266)

Summary model of effects of Zeb1, Zeb2, and Zeb1/2 double deletion on hematopoietic system development and steady-state hematopoiesis. by Jueqiong Wang (11467505)

“…Unlike <i>Zeb2</i> KOs LSK, ST-HSC and MPP numbers are down in Zeb1 hematopoietic null mice and display multilineage differentiation defects with decreased numbers of progenitors and mature hematopoietic cells particularly T cells with mice developing thymic atrophy [<a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3001394#pbio.3001394.ref062" target="_blank">62</a>]. …”

Depletion of SAMHD1 induces cell cycle delay and spontaneous DNA damage response. by Kiwon Park (6492266)

Effect of CA on cell proliferation and apoptosis. by Lucia Natarelli (823310)

Effect of CA on glucose uptake. by Lucia Natarelli (823310)

Proposed mechanisms of the hypoglycemic and hypolipidemic effect of SIK1. by DaoFei Song (6871388)

“…<p>Schematic representation of the role of SIK1 in amelioration of T2DM with NAFLD. Overexpression of SIK1 can contribute to preventing hyperglycemia and hepatic lipid accumulation through suppressing gluconeogenesis and lipogenesis with a decrease in the expressions of CRTC2, PEPCK, G6Pase, SREBP-1c, FAS and ACC in liver, thus reducing fasting blood glucose, serum TC, serum TG, hepatic TG and liver weight. …”

Image 2_Exploring the liver microenvironment following successful therapy for HCV: gene expression profiling and residual T cell infiltration.tif by Daniel E. Millian (20296458)

“…Post-treatment, liver enzymes decreased, inflammatory scores improved, and type I interferon pathways were restored, yet 14 of 17 patients (82.3%, 95% CI: 64.2–100%) retained persistent lymphocytic infiltrates. …”

DataSheet5_First-Line ICI Monotherapies for Advanced Non-small-cell Lung Cancer Patients With PD-L1 of at Least 50%: A Cost-Effectiveness Analysis.docx by Qiao Liu (346535)

“…</p><p>Conclusion: For advanced NSCLC patients with PD-L1 of at least 50%, cemiplimab was a cost-effective option compared with pembrolizumab and a dominant alternative against atezolizumab. …”